alternatives to glp-1 drugs for weight loss A new FDA-approved obesity pill could offer a lower-cost alternative injectable like Ozempic and Mounjaro. In a major clinical trial, people taking the highest dose lost about 11% of GLP-1 Drug Savings: A Complete
Description
Ensuring equitable access to effective treatments is essential for addressing the global obesity epidemic
Huang S, Ma S, Ning M, Yang W, Ye Y, Zhang L, et al
An aromatic moiety establishes hydrophobic interactions within the S1 pocket involving the amino acid residues of Tyr631, Val656, Trp659, Tyr662, Tyr666, and Val711
Hemodynamic disturbances play a central role in DKD progression
Recent head-to-head studies suggest that Mounjaro may offer even greater average weight loss compared to Ozempic at higher doses
